Aegis Capital Starts Recro Pharma (REPH) at Buy

November 14, 2016 7:45 AM EST
Get Alerts REPH Hot Sheet
Price: $6.67 +0.91%

Rating Summary:
    5 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 21 | Down: 36 | New: 11
Trade REPH Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Aegis Capital initiated coverage on Recro Pharma (NASDAQ: REPH) with a Buy rating and a price target of $21.00.

For an analyst ratings summary and ratings history on Recro Pharma click here. For more ratings news on Recro Pharma click here.

Shares of Recro Pharma closed at $8.04 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Add Your Comment